Drotrecogin alpha (activated) in neonatal septic shock.

David Frommhold,Alexandra Birle,Otwin Linderkamp,Eugen Zilow,Johannes Pöschl

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES（2009）

引用 13|浏览7

暂无评分

摘要

A 12-d-old neonate suffering from group B streptococcal septic shock was treated with 24 mu g/kg/h recombinant human activated protein C [rhAPC, drotrecogin alpha ( activated)] for 96 h. The protein C activity increased from 5% to 53% after rhAPC infusion. The patient recovered within 14 d without any adverse effects.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要